Genprex Stock Analysis

Genprex Stock Analysis Notes

The company recorded a loss per share of 10.69. Genprex had not issued any dividends in recent years. The entity had 1:40 split on the 2nd of February 2024. Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas. Genprex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To learn more about Genprex call Ryan MS at 877-774-4679 or check out https://www.genprex.com.

Genprex Investment Alerts

Genprex Upcoming and Recent Events

Genprex Largest EPS Surprises

View All Earnings Estimates

Genprex Stock Institutional Investors

Note, although Genprex's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Genprex Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.7 M.

Genprex Profitablity

Management Efficiency

Genprex has return on total asset (ROA) of (1.4594) % which means that it has lost $1.4594 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1888) %, meaning that it created substantial loss on money invested by shareholders. Genprex's management efficiency ratios could be used to measure how well Genprex manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -3.27 in 2024. Return On Capital Employed is likely to drop to -4.4 in 2024. At this time, Genprex's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 49.1 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 1.7 M in 2024.

Technical Drivers

As of the 22nd of November, Genprex retains the Risk Adjusted Performance of 0.0932, downside deviation of 11.17, and Market Risk Adjusted Performance of (0.55). Genprex technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Genprex Price Movement Analysis

Genprex Insider Trading Activities

Genprex Outstanding Bonds

Genprex Predictive Daily Indicators

Genprex Forecast Models

Genprex's time-series forecasting models are one of many Genprex's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genprex's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Genprex prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genprex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genprex. By using and applying Genprex Stock analysis, traders can create a robust methodology for identifying Genprex entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Genprex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Genprex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Genprex stock analysis indicators help investors evaluate how Genprex stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Genprex shares will generate the highest return on investment. By understating and applying Genprex stock analysis, traders can identify Genprex position entry and exit signals to maximize returns.

When running Genprex's price analysis, check to measure Genprex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genprex is operating at the current time. Most of Genprex's value examination focuses on studying past and present price action to predict the probability of Genprex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genprex's price. Additionally, you may evaluate how the addition of Genprex to your portfolios can decrease your overall portfolio volatility.